Study: Fragile X syndrome neurons can be restored
Whitehead Institute researchers are using a modified CRISPR/Cas9-guided activation strategy to investigate the most frequent cause of intellectual disability in males.
Whitehead Institute researchers are using a modified CRISPR/Cas9-guided activation strategy to investigate the most frequent cause of intellectual disability in males.
Department of Biology kicks off IAP seminar series with a lecture by synthetic-biology visionary George Church.
Study explains why mutations that would seemingly affect all cells lead to face-specific birth defects.
Study: State-level disclosure laws affect patients’ eagerness to have their DNA tested.
Study shows that, like proteins, genomes must fold appropriately to function properly and that some transcription factors provide the structural support.
Whitehead Institute researchers have pinpointed distinct muscle subsets that orchestrate and pattern regrowth.
New delivery system developed by MIT team deletes disease-causing genes and reduces cholesterol.
Improved methods validate the use of blood samples for studying patients’ cancer genomes.
Studies in mice show improved social interaction and cognition from a potential therapeutic for a syndrome that often results in autism.
“REPAIR” system edits RNA, rather than DNA; has potential to treat diseases without permanently affecting the genome.
Biological engineers identify genes that protect against protein linked to Parkinson’s disease.
Experiments confirm hypothesis about how the genome becomes organized into “neighborhoods.”
MIT associate professor and member of the Broad Institute and McGovern Institute recognized for commitment to invention, collaboration, and mentorship.
Five recipients honored for their fundamental and complementary accomplishments related to CRISPR-Cas9.
Biophysicist Ibrahim Cissé and cell biologist Gene-Wei Li honored as Pew Scholars; postdocs Ana Fiszbein and María Inda are named Pew Latin American Fellows.